Pipeline Bomb: Analysts Review Celgene's Crohn's Diseases Failure By: Benzinga via Benzinga October 20, 2017 at 14:14 PM EDT Celgene Corporation (NASDAQ: CELG) stock plummeted 10 percent Friday after the company reported that its testing of GED-0301 for ... Read More >> Related Stocks: Celgene Corp UBS Group Ag ADR